Wangdi Liao

427 total citations
21 papers, 293 citations indexed

About

Wangdi Liao is a scholar working on Surgery, Molecular Biology and Gastroenterology. According to data from OpenAlex, Wangdi Liao has authored 21 papers receiving a total of 293 indexed citations (citations by other indexed papers that have themselves been cited), including 9 papers in Surgery, 5 papers in Molecular Biology and 5 papers in Gastroenterology. Recurrent topics in Wangdi Liao's work include Inflammatory Bowel Disease (5 papers), Diagnosis and treatment of tuberculosis (4 papers) and Gastrointestinal disorders and treatments (3 papers). Wangdi Liao is often cited by papers focused on Inflammatory Bowel Disease (5 papers), Diagnosis and treatment of tuberculosis (4 papers) and Gastrointestinal disorders and treatments (3 papers). Wangdi Liao collaborates with scholars based in China and United Kingdom. Wangdi Liao's co-authors include Nonghua Lv, Zhenhua Zhu, Xu Shu, Guohua Li, Ruipu Sun, Ying Ying, Xuan Zhu, Cong He, Chao Peng and Xiaomin Gong and has published in prestigious journals such as Medicine, World Journal of Gastroenterology and Frontiers in Pharmacology.

In The Last Decade

Wangdi Liao

18 papers receiving 291 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Wangdi Liao China 10 149 87 58 57 43 21 293
Longgui Ning China 8 86 0.6× 57 0.7× 45 0.8× 45 0.8× 63 1.5× 12 258
Zhongyin Zhou China 9 129 0.9× 53 0.6× 30 0.5× 51 0.9× 27 0.6× 17 278
Harish P. Janardhan United States 11 263 1.8× 60 0.7× 31 0.5× 40 0.7× 50 1.2× 16 401
S. R. Hamilton United States 8 73 0.5× 94 1.1× 49 0.8× 53 0.9× 45 1.0× 16 285
Samir Mesli France 7 90 0.6× 53 0.6× 80 1.4× 24 0.4× 65 1.5× 12 230
Marisol Ramirez‐Solano United States 7 145 1.0× 49 0.6× 29 0.5× 21 0.4× 16 0.4× 20 277
Gilat Efroni Israel 8 170 1.1× 18 0.2× 32 0.6× 30 0.5× 37 0.9× 14 297
Masahide Tojo Japan 9 340 2.3× 94 1.1× 104 1.8× 36 0.6× 67 1.6× 12 487
Shengbao Li China 10 181 1.2× 114 1.3× 17 0.3× 26 0.5× 29 0.7× 30 381
Fachao Zhi China 11 101 0.7× 122 1.4× 37 0.6× 17 0.3× 30 0.7× 21 324

Countries citing papers authored by Wangdi Liao

Since Specialization
Citations

This map shows the geographic impact of Wangdi Liao's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Wangdi Liao with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Wangdi Liao more than expected).

Fields of papers citing papers by Wangdi Liao

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Wangdi Liao. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Wangdi Liao. The network helps show where Wangdi Liao may publish in the future.

Co-authorship network of co-authors of Wangdi Liao

This figure shows the co-authorship network connecting the top 25 collaborators of Wangdi Liao. A scholar is included among the top collaborators of Wangdi Liao based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Wangdi Liao. Wangdi Liao is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Wang, Zhizhi, et al.. (2024). Treatment with antituberculosis agents after tuberculosis activation during ustekinumab treatment: Safety and effectiveness. Arab Journal of Gastroenterology. 26(1). 23–25.
2.
Liu, Shi, et al.. (2023). Risk factors for inadequate bowel preparation before colonoscopy: a retrospective cohort study. BMC Gastroenterology. 23(1). 204–204. 3 indexed citations
3.
Yang, Yihan, Jiawei Zhong, Zhenhua Zhu, et al.. (2022). Incidence and risk factors for rebleeding after emergency endoscopic hemostasis for marginal ulcer bleeding. Clinics and Research in Hepatology and Gastroenterology. 46(8). 101953–101953. 2 indexed citations
4.
Lai, Yongkang, Zhenhua Zhu, Xiaolin Pan, et al.. (2022). Development and validation of a model to predict rebleeding within three days after endoscopic hemostasis for high-risk peptic ulcer bleeding. BMC Gastroenterology. 22(1). 64–64. 11 indexed citations
5.
Fu, Yunfeng, et al.. (2022). Global research trends of immunotherapy and biotherapy for inflammatory bowel disease: a bibliometric analysis from 2002 to 2021. BioMedical Engineering OnLine. 21(1). 42–42. 8 indexed citations
6.
Wang, Kaiyi, Xin Li, Yu Chen, et al.. (2022). Hereditary hemorrhagic telangiectasis with juvenile polyposis syndrome: a case report. Therapeutic Advances in Gastroenterology. 15. 1098325889–1098325889.
7.
Jiang, Lanxin, Xiaomin Gong, Wangdi Liao, Nonghua Lv, & Runwei Yan. (2021). Molecular targeted treatment and drug delivery system for gastric cancer. Journal of Cancer Research and Clinical Oncology. 147(4). 973–986. 24 indexed citations
8.
Liu, Zhiyi, Wangdi Liao, Ruipu Sun, et al.. (2021). Metformin Affects Gut Microbiota Composition and Diversity Associated with Amelioration of Dextran Sulfate Sodium-Induced Colitis in Mice. Frontiers in Pharmacology. 12. 640347–640347. 33 indexed citations
9.
He, Cong, Huan Wang, Chen Yu, et al.. (2021). Alterations of Gut Microbiota in Patients With Intestinal Tuberculosis That Different From Crohn’s Disease. Frontiers in Bioengineering and Biotechnology. 9. 673691–673691. 12 indexed citations
11.
Lai, Yongkang, Zhenhua Zhu, Wangdi Liao, et al.. (2020). Risk Factors for Rebleeding after Emergency Endoscopic Treatment of Dieulafoy Lesion. Canadian Journal of Gastroenterology and Hepatology. 2020. 1–8. 8 indexed citations
12.
He, Cong, Huan Wang, Wangdi Liao, et al.. (2019). Characteristics of mucosa-associated gut microbiota during treatment in Crohn’s disease. World Journal of Gastroenterology. 25(18). 2204–2216. 32 indexed citations
13.
Zhu, Na, Ruipu Sun, Wangdi Liao, et al.. (2018). Metformin Inhibits Chemokine Expression Through the AMPK/NF-κB Signaling Pathway. Journal of Interferon & Cytokine Research. 38(9). 363–369. 40 indexed citations
14.
Li, Bowen, et al.. (2018). Acute Myeloid Leukemia with Myelodysplasia-Related Changes in a Patient with Crohn’s Disease Treated with Immunosuppressive Therapy. Case Reports in Oncology. 11(2). 573–576. 2 indexed citations
15.
Zhu, Zhenhua, et al.. (2018). Ulcerative colitis followed by the development of typical intestinal Behçet disease. Medicine. 97(7). e9882–e9882. 2 indexed citations
16.
Liao, Wangdi, Guohua Li, Yu You, et al.. (2017). Antitumor activity of Notch‑1 inhibition in human colorectal carcinoma cells. Oncology Reports. 39(3). 1063–1071. 36 indexed citations
17.
Zhu, Zhenhua, Mengling Li, Xu Shu, et al.. (2016). Thalidomide is a therapeutic agent that is effective in inducing and maintaining endoscopic remission in adult CD patients. Clinics and Research in Hepatology and Gastroenterology. 41(2). 210–216. 9 indexed citations
18.
Bai, Aiping, et al.. (2015). Catecholamine Mediates Psychological Stress-Induced Colitis Through a2-Adrenoreceptor. Journal of Interferon & Cytokine Research. 35(7). 580–584. 8 indexed citations
20.
He, Yao, Yujun Chen, Hong Yang, et al.. (2012). Clinical and colonoscopic characteristics of Crohn disease and intestinal tuberculosis. Zhonghua xiaohua neijing zazhi. 29(6). 325–328.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026